(S)-naringenin multiple interactions ISO KRAS (Homo sapiens) 6480464 [naringenin metabolite co-treated with bisphenol A] results in increased expression of KRAS mRNA CTD PMID:36235125 (trichloromethyl)benzene increases mutagenesis ISO Kras (Mus musculus) 6480464 benzotrichloride results in increased mutagenesis of KRAS gene CTD PMID:8508514 1,1-dichloroethene increases expression ISO Kras (Mus musculus) 6480464 vinylidene chloride results in increased expression of KRAS mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression ISO Kras (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of KRAS mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Kras (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KRAS mRNA CTD PMID:22206623 1-nitropyrene increases mutagenesis ISO Kras (Mus musculus) 6480464 1-nitropyrene results in increased mutagenesis of KRAS gene CTD PMID:10396879 more ... 1-nitropyrene multiple interactions ISO Kras (Mus musculus) 6480464 [1-nitropyrene co-treated with KC 400] results in increased mutagenesis of KRAS gene more ... CTD PMID:10396879 more ... 17alpha-ethynylestradiol multiple interactions ISO Kras (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRAS mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of KRAS mRNA CTD PMID:29097150 17beta-estradiol decreases expression ISO KRAS (Homo sapiens) 6480464 Estradiol results in decreased expression of KRAS mRNA CTD PMID:16474171 17beta-estradiol increases expression ISO KRAS (Homo sapiens) 6480464 Estradiol results in increased expression of KRAS mRNA CTD PMID:23094148 2,2-Bis(bromomethyl)propane-1,3-diol increases mutagenesis ISO Kras (Mus musculus) 6480464 2 more ... CTD PMID:14713543 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO KRAS (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRAS mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Kras (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of KRAS mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO KRAS (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA CTD PMID:11007951 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO KRAS (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of KRAS mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Kras (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRAS mRNA CTD PMID:14708085 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Kras (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Kras (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRAS mRNA more ... CTD PMID:11884234 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of KRAS mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases mutagenesis ISO Kras (Mus musculus) 6480464 Butylated Hydroxytoluene results in increased mutagenesis of KRAS gene CTD PMID:20101149 2-trans,6-trans-farnesyl diphosphate multiple interactions EXP 6480464 [FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] CTD PMID:10673434 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4 and 5-f)quinoline results in increased mutagenesis of KRAS gene CTD PMID:8844820 3-methylcholanthrene multiple interactions ISO Kras (Mus musculus) 6480464 Methylcholanthrene promotes the reaction [GATA6 protein binds to KRAS exon] and Methylcholanthrene promotes the reaction [NFYA protein binds to KRAS exon] CTD PMID:16271038 3-methylcholanthrene increases mutagenesis ISO Kras (Mus musculus) 6480464 Methylcholanthrene results in increased mutagenesis of KRAS gene CTD PMID:11195466 and PMID:20101149 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases mutagenesis EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of KRAS gene CTD PMID:18271921 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO Kras (Mus musculus) 6480464 [Lipopolysaccharides co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of KRAS gene CTD PMID:21868532 4-nitrophenol decreases expression ISO Kras (Mus musculus) 6480464 4-nitrophenol results in decreased expression of KRAS mRNA CTD PMID:34673133 4-vinylcyclohexene dioxide affects expression ISO Kras (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of KRAS mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine multiple interactions ISO KRAS (Homo sapiens) 6480464 Decitabine inhibits the reaction [arsenite results in increased expression of KRAS protein] CTD PMID:24704393 5-fluorouracil decreases expression ISO KRAS (Homo sapiens) 6480464 Fluorouracil results in decreased expression of KRAS protein CTD PMID:15585135 and PMID:16803524 5-Methylchrysene increases mutagenesis ISO Kras (Mus musculus) 6480464 5-methylchrysene results in increased mutagenesis of KRAS gene CTD PMID:8571376 and PMID:9659573 acrolein decreases expression ISO KRAS (Homo sapiens) 6480464 Acrolein results in decreased expression of KRAS protein CTD PMID:24812010 actinomycin D multiple interactions ISO KRAS (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B mRNA] CTD PMID:27222248 afimoxifene affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS gene affects the susceptibility to afimoxifene CTD PMID:21482774 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KRAS mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of KRAS mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO KRAS (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of KRAS mRNA CTD PMID:24449571 Antrocin decreases expression ISO KRAS (Homo sapiens) 6480464 antrocin analog results in decreased expression of KRAS protein CTD PMID:36565974 aristolochic acid A increases mutagenesis EXP 6480464 aristolochic acid I results in increased mutagenesis of KRAS gene CTD PMID:21642617 aristolochic acid A decreases expression ISO KRAS (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of KRAS mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Kras (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of KRAS mRNA and Chlorodiphenyl (54% Chlorine) results in decreased expression of KRAS protein CTD PMID:23650126 Aroclor 1254 affects localization ISO Kras (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) affects the localization of KRAS protein CTD PMID:9525281 ARS-1620 affects binding ISO KRAS (Homo sapiens) 6480464 ARS-1620 binds to KRAS protein mutant form CTD PMID:31666701 arsane multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS affects the reaction [Arsenic results in increased phosphorylation of MAPK1 protein] more ... CTD PMID:25273566 arsane increases mutagenesis ISO KRAS (Homo sapiens) 6480464 Arsenic results in increased mutagenesis of KRAS gene CTD PMID:32344290 arsane affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS affects the susceptibility to Arsenic CTD PMID:25273566 arsenic atom multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS affects the reaction [Arsenic results in increased phosphorylation of MAPK1 protein] more ... CTD PMID:25273566 arsenic atom increases mutagenesis ISO KRAS (Homo sapiens) 6480464 Arsenic results in increased mutagenesis of KRAS gene CTD PMID:32344290 arsenic atom affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS affects the susceptibility to Arsenic CTD PMID:25273566 arsenite(3-) multiple interactions ISO KRAS (Homo sapiens) 6480464 decitabine inhibits the reaction [arsenite results in increased expression of KRAS protein] and MIRLET7C mRNA inhibits the reaction [arsenite results in increased expression of KRAS protein] CTD PMID:24704393 arsenite(3-) increases mutagenesis ISO KRAS (Homo sapiens) 6480464 arsenite results in increased mutagenesis of KRAS gene mutant form CTD PMID:31009485 arsenite(3-) increases expression ISO KRAS (Homo sapiens) 6480464 arsenite results in increased expression of KRAS protein CTD PMID:24704393 asbestos increases mutagenesis ISO KRAS (Homo sapiens) 6480464 Asbestos results in increased mutagenesis of KRAS gene CTD PMID:12725029 Benz[j]aceanthrylene increases mutagenesis ISO Kras (Mus musculus) 6480464 benz(j)aceanthrylene results in increased mutagenesis of KRAS gene CTD PMID:9659573 benzene increases response to substance ISO Kras (Mus musculus) 6480464 KRAS gene polymorphism results in increased susceptibility to Benzene CTD PMID:12807761 benzo[a]pyrene increases expression ISO Kras (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of KRAS mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO KRAS (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of KRAS promoter CTD PMID:27901495 benzo[a]pyrene increases mutagenesis ISO Kras (Mus musculus) 6480464 Benzo(a)pyrene results in increased mutagenesis of KRAS gene CTD PMID:19658153 more ... benzo[a]pyrene diol epoxide I increases expression ISO KRAS (Homo sapiens) 6480464 7 more ... CTD PMID:18567617 benzo[a]pyrene diol epoxide I decreases expression ISO KRAS (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 benzo[b]fluoranthene increases mutagenesis ISO Kras (Mus musculus) 6480464 benzo(b)fluoranthene results in increased mutagenesis of KRAS gene CTD PMID:8571376 and PMID:9659573 bisphenol A decreases expression ISO KRAS (Homo sapiens) 6480464 bisphenol A results in decreased expression of KRAS mRNA CTD PMID:16474171 bisphenol A increases expression ISO KRAS (Homo sapiens) 6480464 bisphenol A results in increased expression of KRAS mRNA CTD PMID:36982678 bisphenol A multiple interactions ISO KRAS (Homo sapiens) 6480464 [bisphenol A co-treated with Quercetin metabolite] results in increased expression of KRAS mRNA more ... CTD PMID:36235125 and PMID:36982678 bisphenol A decreases expression ISO Kras (Mus musculus) 6480464 bisphenol A results in decreased expression of KRAS mRNA CTD PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of KRAS gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KRAS mRNA CTD PMID:29097150 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of KRAS mRNA CTD PMID:25181051 bisphenol A increases expression ISO Kras (Mus musculus) 6480464 bisphenol A results in increased expression of KRAS mRNA CTD PMID:26063408 bisphenol A increases mutagenesis ISO KRAS (Homo sapiens) 6480464 bisphenol A results in increased mutagenesis of KRAS gene CTD PMID:11342245 bleomycin A2 multiple interactions ISO Kras (Mus musculus) 6480464 [Bleomycin co-treated with 1-nitropyrene] results in increased mutagenesis of KRAS gene CTD PMID:12616606 buta-1,3-diene increases mutagenesis ISO Kras (Mus musculus) 6480464 1 and 3-butadiene results in increased mutagenesis of KRAS gene CTD PMID:11397402 cadmium atom increases expression ISO KRAS (Homo sapiens) 6480464 Cadmium results in increased expression of KRAS mRNA and Cadmium results in increased expression of KRAS protein CTD PMID:20049202 cadmium atom decreases expression ISO KRAS (Homo sapiens) 6480464 Cadmium results in decreased expression of KRAS mRNA CTD PMID:21120746 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KRAS mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein inhibits the reaction [Cadmium Chloride results in decreased expression of MIR155 mRNA] more ... CTD PMID:27510461 cadmium dichloride increases expression ISO KRAS (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of KRAS mRNA and Cadmium Chloride results in increased expression of KRAS protein CTD PMID:23811327 more ... cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of KRAS mRNA CTD PMID:32553926 cannabidiol multiple interactions ISO KRAS (Homo sapiens) 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of KRAS mRNA CTD PMID:32992648 carbamazepine affects expression ISO KRAS (Homo sapiens) 6480464 Carbamazepine affects the expression of KRAS mRNA CTD PMID:24752500 carbon nanotube increases mutagenesis ISO Kras (Mus musculus) 6480464 Nanotubes and Carbon results in increased mutagenesis of KRAS gene CTD PMID:24213921 ceruletide multiple interactions ISO Kras (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [[KRAS protein mutant form co-treated with Ceruletide] results in increased expression of BRD4 protein] more ... CTD PMID:26390243 CGP 52608 multiple interactions ISO KRAS (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to KRAS gene] CTD PMID:28238834 chloroethene multiple interactions ISO KRAS (Homo sapiens) 6480464 CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of KRAS gene] more ... CTD PMID:12705718 more ... chloroethene increases mutagenesis ISO KRAS (Homo sapiens) 6480464 Vinyl Chloride results in increased mutagenesis of KRAS gene CTD PMID:10629081 more ... chloroethene increases response to substance ISO Kras (Mus musculus) 6480464 KRAS gene polymorphism results in increased susceptibility to Vinyl Chloride CTD PMID:12807761 chloroprene increases mutagenesis ISO Kras (Mus musculus) 6480464 Chloroprene results in increased mutagenesis of KRAS gene CTD PMID:10223196 and PMID:11397402 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of KRAS mRNA CTD PMID:18668222 chymostatin multiple interactions ISO KRAS (Homo sapiens) 6480464 chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of AGT protein] more ... CTD PMID:33380422 cisplatin multiple interactions ISO KRAS (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of KRAS mRNA CTD PMID:27392435 cisplatin decreases expression ISO KRAS (Homo sapiens) 6480464 Cisplatin results in decreased expression of KRAS mRNA CTD PMID:27392435 clofibrate increases expression ISO Kras (Mus musculus) 6480464 Clofibrate results in increased expression of KRAS mRNA CTD PMID:23811191 cobalt atom increases mutagenesis EXP 6480464 Cobalt results in increased mutagenesis of KRAS gene CTD PMID:34468815 cobalt atom increases mutagenesis ISO Kras (Mus musculus) 6480464 Cobalt results in increased mutagenesis of KRAS gene CTD PMID:34468815 cobimetinib increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in increased susceptibility to cobimetinib CTD PMID:22084396 cobimetinib multiple interactions ISO KRAS (Homo sapiens) 6480464 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:22084396 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of KRAS mRNA and Copper results in increased expression of KRAS mRNA CTD PMID:17418555 and PMID:22465980 copper atom multiple interactions ISO KRAS (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of KRAS mRNA CTD PMID:30911355 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of KRAS mRNA and Copper results in increased expression of KRAS mRNA CTD PMID:17418555 and PMID:22465980 copper(0) multiple interactions ISO KRAS (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of KRAS mRNA CTD PMID:30911355 coumestrol decreases expression ISO KRAS (Homo sapiens) 6480464 Coumestrol results in decreased expression of KRAS mRNA CTD PMID:19167446 crizotinib decreases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in decreased susceptibility to crizotinib CTD PMID:22235099 cumene multiple interactions ISO Kras (Mus musculus) 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of CCN1 mRNA more ... CTD PMID:18648096 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of KRAS mRNA CTD PMID:26577399 curcumin decreases expression ISO KRAS (Homo sapiens) 6480464 Curcumin analog results in decreased expression of KRAS mRNA and Curcumin results in decreased expression of KRAS mRNA CTD PMID:17041101 curcumin multiple interactions ISO Kras (Mus musculus) 6480464 Curcumin affects the reaction [KRAS protein affects the localization of TRP53 protein] and Curcumin inhibits the reaction [KRAS protein results in decreased expression of XPO1 protein] CTD PMID:21519798 cycloheximide multiple interactions ISO KRAS (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA] CTD PMID:11007951 Cyclopenta[cd]pyrene increases mutagenesis ISO Kras (Mus musculus) 6480464 cyclopenta(c and d)pyrene results in increased mutagenesis of KRAS gene CTD PMID:9659573 dabrafenib multiple interactions ISO KRAS (Homo sapiens) 6480464 [KRAS protein affects the susceptibility to dabrafenib] which affects the expression of TNFRSF10B protein more ... CTD PMID:27222248 dabrafenib affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the susceptibility to dabrafenib CTD PMID:27222248 dextran sulfate multiple interactions ISO Kras (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KRAS mRNA and Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of KRAS protein] CTD PMID:29950665 and PMID:32272095 dextran sulfate decreases expression ISO Kras (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of KRAS protein CTD PMID:32272095 dibenzo[a,l]pyrene increases mutagenesis ISO Kras (Mus musculus) 6480464 dibenzo(a and l)pyrene results in increased mutagenesis of KRAS gene CTD PMID:9659573 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of KRAS mRNA CTD PMID:18636392 diclofenac affects expression ISO KRAS (Homo sapiens) 6480464 Diclofenac affects the expression of KRAS mRNA CTD PMID:24752500 dioxygen multiple interactions ISO KRAS (Homo sapiens) 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of KRAS mRNA and [Oxygen co-treated with Ozone] results in decreased expression of KRAS mRNA CTD PMID:32992648 dorsomorphin multiple interactions ISO KRAS (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO KRAS (Homo sapiens) 6480464 Doxorubicin results in decreased expression of KRAS mRNA CTD PMID:29803840 erlotinib hydrochloride increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein results in increased susceptibility to Erlotinib Hydrochloride CTD PMID:20705357 ethanol affects splicing ISO Kras (Mus musculus) 6480464 Ethanol affects the splicing of KRAS mRNA CTD PMID:30319688 farnesyl diphosphate multiple interactions EXP 6480464 [FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] CTD PMID:10673434 flutamide increases expression EXP 6480464 Flutamide results in increased expression of KRAS mRNA CTD PMID:24136188 folic acid increases expression ISO Kras (Mus musculus) 6480464 Folic Acid results in increased expression of KRAS mRNA CTD PMID:2566606 folic acid multiple interactions ISO Kras (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KRAS mRNA CTD PMID:22206623 folic acid decreases expression ISO Kras (Mus musculus) 6480464 Folic Acid results in decreased expression of KRAS mRNA CTD PMID:25629700 GDP multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form inhibits the reaction [SOS1 protein inhibits the reaction [Guanosine Diphosphate binds to KRAS protein]] and SOS1 protein inhibits the reaction [Guanosine Diphosphate binds to KRAS protein] CTD PMID:28154176 GDP affects binding ISO KRAS (Homo sapiens) 6480464 Guanosine Diphosphate binds to KRAS protein and Guanosine Diphosphate binds to KRAS protein mutant form CTD PMID:28154176 gefitinib affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form affects the susceptibility to gefitinib CTD PMID:17270025 gefitinib decreases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein results in decreased susceptibility to gefitinib CTD PMID:28739874 gefitinib multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the reaction [EGFR protein affects the susceptibility to gefitinib] CTD PMID:28739874 genistein decreases expression ISO KRAS (Homo sapiens) 6480464 Genistein results in decreased expression of KRAS mRNA CTD PMID:15256057 and PMID:16474171 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KRAS mRNA CTD PMID:22061828 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KRAS mRNA] CTD PMID:28428697 GTP multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form inhibits the reaction [RASA1 protein promotes the reaction [KRAS protein results in increased hydrolysis of Guanosine Triphosphate]] and RASA1 protein promotes the reaction [KRAS protein results in increased hydrolysis of Guanosine Triphosphate] CTD PMID:28154176 GTP affects binding ISO KRAS (Homo sapiens) 6480464 Guanosine Triphosphate binds to KRAS protein and Guanosine Triphosphate binds to KRAS protein mutant form CTD PMID:28154176 GTP increases hydrolysis ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in increased hydrolysis of Guanosine Triphosphate and KRAS protein results in increased hydrolysis of Guanosine Triphosphate CTD PMID:28154176 guanosine multiple interactions ISO KRAS (Homo sapiens) 6480464 Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of KRAS mRNA CTD PMID:15860345 hydrogen peroxide multiple interactions ISO Kras (Mus musculus) 158013773 melatonin inhibits the reaction [hydrogen peroxide increases expression of Kras protein in C-kit+ cardiac progenitor cells] RGD hydrogen peroxide increases expression ISO Kras (Mus musculus) 158013773 hydrogen peroxide increases expression of Kras protein in C-kit+ cardiac progenitor cells RGD hydroquinone multiple interactions ISO KRAS (Homo sapiens) 6480464 [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein CTD PMID:28444915 hydroquinone increases expression ISO KRAS (Homo sapiens) 6480464 hydroquinone results in increased expression of KRAS protein CTD PMID:27515134 hydroquinone affects expression ISO KRAS (Homo sapiens) 6480464 hydroquinone affects the expression of KRAS mRNA CTD PMID:27515134 hydroxyurea decreases expression ISO Kras (Mus musculus) 6480464 Hydroxyurea results in decreased expression of KRAS mRNA CTD PMID:12929121 ionomycin multiple interactions ISO KRAS (Homo sapiens) 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] more ... CTD PMID:15263067 irbesartan multiple interactions ISO Kras (Mus musculus) 6480464 Irbesartan inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN2A protein] CTD PMID:33380422 irbesartan multiple interactions ISO KRAS (Homo sapiens) 6480464 Irbesartan inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN1A protein] CTD PMID:33380422 isoprenaline increases expression ISO Kras (Mus musculus) 6480464 Isoproterenol results in increased expression of KRAS mRNA CTD PMID:21335049 isoprene increases mutagenesis ISO Kras (Mus musculus) 6480464 isoprene results in increased mutagenesis of KRAS gene CTD PMID:11397402 and PMID:9111215 isotretinoin decreases expression ISO KRAS (Homo sapiens) 6480464 Isotretinoin results in decreased expression of KRAS mRNA CTD PMID:20436886 ivermectin decreases expression ISO KRAS (Homo sapiens) 6480464 Ivermectin results in decreased expression of KRAS protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of KRAS mRNA CTD PMID:19700661 lapatinib multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the reaction [EGFR protein affects the susceptibility to lapatinib] CTD PMID:28739874 lapatinib decreases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein results in decreased susceptibility to lapatinib CTD PMID:28739874 lead diacetate decreases expression ISO Kras (Mus musculus) 6480464 lead acetate results in decreased expression of KRAS mRNA CTD PMID:21829687 lead diacetate multiple interactions ISO KRAS (Homo sapiens) 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA CTD PMID:22839698 lead diacetate increases expression ISO Kras (Mus musculus) 6480464 lead acetate results in increased expression of KRAS mRNA CTD PMID:25270620 lead(0) increases expression ISO Kras (Mus musculus) 6480464 Lead results in increased expression of KRAS protein CTD PMID:19727529 lipopolysaccharide multiple interactions ISO Kras (Mus musculus) 6480464 [Lipopolysaccharides co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of KRAS gene CTD PMID:21868532 lipopolysaccharide increases expression ISO KRAS (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of KRAS mRNA CTD PMID:35953652 losartan multiple interactions ISO KRAS (Homo sapiens) 6480464 Losartan inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN1A protein] and Losartan inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN2A protein] CTD PMID:33380422 lovastatin decreases prenylation ISO KRAS (Homo sapiens) 6480464 Lovastatin results in decreased prenylation of KRAS protein CTD PMID:16156861 lovastatin increases expression ISO Kras (Mus musculus) 6480464 Lovastatin results in increased expression of KRAS protein CTD PMID:12907238 lovastatin affects localization ISO Kras (Mus musculus) 6480464 Lovastatin affects the localization of KRAS protein CTD PMID:12106604 lovastatin increases activity ISO Kras (Mus musculus) 6480464 Lovastatin results in increased activity of KRAS protein CTD PMID:17005160 luzindole multiple interactions ISO Kras (Mus musculus) 158013773 luzindole inhibits the reaction [melatonin inhibits the reaction [hydrogen peroxide increases expression of Kras protein in C-kit+ cardiac progenitor cells]] RGD manumycin A multiple interactions ISO KRAS (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 manumycin A decreases activity ISO KRAS (Homo sapiens) 6480464 manumycin results in decreased activity of KRAS protein CTD PMID:19409983 MeIQx increases mutagenesis EXP 6480464 2-amino-3 more ... CTD PMID:18271921 mercury dibromide decreases expression ISO KRAS (Homo sapiens) 6480464 mercuric bromide results in decreased expression of KRAS mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO KRAS (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA CTD PMID:27188386 metformin multiple interactions ISO KRAS (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of KRAS mRNA CTD PMID:29309887 methohexital multiple interactions ISO KRAS (Homo sapiens) 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 methotrexate increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS gene mutant form results in increased susceptibility to Methotrexate CTD PMID:24688052 methotrexate decreases expression ISO KRAS (Homo sapiens) 6480464 Methotrexate results in decreased expression of KRAS mRNA more ... CTD PMID:24688052 metyrapone multiple interactions EXP 6480464 [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of KRAS mRNA CTD PMID:37088303 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of KRAS mRNA CTD PMID:20928830 N,N-bis(2-hydroxypropyl)nitrosamine increases mutagenesis EXP 6480464 diisopropanolnitrosamine results in increased mutagenesis of KRAS gene CTD PMID:18271921 N-acetyl-L-cysteine multiple interactions ISO KRAS (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO KRAS (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KRAS mRNA CTD PMID:31806706 N-ethyl-N-nitrosourea multiple interactions ISO Kras (Mus musculus) 6480464 Ethylnitrosourea promotes the reaction [GATA6 protein binds to KRAS exon] and Ethylnitrosourea promotes the reaction [NFYA protein binds to KRAS exon] CTD PMID:16271038 N-ethyl-N-nitrosourea increases mutagenesis ISO Kras (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of KRAS gene CTD PMID:15790496 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KRAS mRNA] CTD PMID:28428697 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of KRAS mRNA CTD PMID:28428697 N-methyl-N-nitrosourea decreases response to substance EXP 6480464 KRAS protein results in decreased susceptibility to Methylnitrosourea CTD PMID:11973638 N-methyl-N-nitrosourea increases mutagenesis ISO Kras (Mus musculus) 6480464 Methylnitrosourea results in increased mutagenesis of KRAS gene CTD PMID:12483526 and PMID:18062963 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of KRAS mRNA CTD PMID:7910516 N-nitrosodiethylamine increases expression ISO Kras (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of KRAS mRNA CTD PMID:26464624 N-nitrosodimethylamine affects localization ISO Kras (Mus musculus) 6480464 Dimethylnitrosamine affects the localization of KRAS protein CTD PMID:11884234 N-nitrosodimethylamine multiple interactions ISO Kras (Mus musculus) 6480464 Dimethylnitrosamine results in decreased expression of and affects the localization of KRAS protein more ... CTD PMID:11884234 and PMID:19555203 nicotinic acid affects localization ISO Kras (Mus musculus) 6480464 Niacin affects the localization of KRAS protein CTD PMID:12106604 ochratoxin A decreases expression ISO KRAS (Homo sapiens) 6480464 ochratoxin A results in decreased expression of KRAS mRNA CTD PMID:30559759 oncrasin-1 increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in increased susceptibility to oncrasin-1 CTD PMID:21443218 oxirane increases mutagenesis ISO Kras (Mus musculus) 6480464 Ethylene Oxide results in increased mutagenesis of KRAS gene CTD PMID:24029818 oxybenzone increases expression ISO KRAS (Homo sapiens) 6480464 oxybenzone results in increased expression of KRAS mRNA CTD PMID:36581016 ozone multiple interactions EXP 6480464 [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of KRAS mRNA more ... CTD PMID:18636392 and PMID:37088303 ozone multiple interactions ISO KRAS (Homo sapiens) 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of KRAS mRNA and [Oxygen co-treated with Ozone] results in decreased expression of KRAS mRNA CTD PMID:32992648 ozone increases expression EXP 6480464 Ozone results in increased expression of KRAS mRNA CTD PMID:16330353 p-chloromercuribenzoic acid decreases expression ISO KRAS (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of KRAS mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO KRAS (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA CTD PMID:27188386 paclitaxel multiple interactions ISO KRAS (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of KRAS mRNA CTD PMID:29309887 paracetamol affects expression ISO Kras (Mus musculus) 6480464 Acetaminophen affects the expression of KRAS mRNA CTD PMID:17562736 PD 0325901 multiple interactions ISO Kras (Mus musculus) 6480464 [mirdametinib affects the susceptibility to KRAS protein] affects the reaction [NVP-BKM120 results in decreased expression of MKI67 protein] CTD PMID:24576621 PD 0325901 multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the reaction [mirdametinib inhibits the reaction [NVP-BKM120 results in increased phosphorylation of MAPK1 protein]] more ... CTD PMID:24576621 pemetrexed increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS gene mutant form results in increased susceptibility to Pemetrexed CTD PMID:24688052 pemetrexed decreases expression ISO KRAS (Homo sapiens) 6480464 Pemetrexed results in decreased expression of KRAS mRNA more ... CTD PMID:24688052 pentobarbital multiple interactions ISO KRAS (Homo sapiens) 6480464 Pentobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 phlorizin decreases expression ISO Kras (Mus musculus) 6480464 Phlorhizin results in decreased expression of KRAS mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO KRAS (Homo sapiens) 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] more ... CTD PMID:15263067 phorbol 13-acetate 12-myristate multiple interactions ISO Kras (Mus musculus) 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS mRNA and [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS protein CTD PMID:16368122 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of KRAS mRNA CTD PMID:15170462 piperonyl butoxide increases mutagenesis ISO KRAS (Homo sapiens) 6480464 Piperonyl Butoxide results in increased mutagenesis of KRAS gene CTD PMID:7565889 pirinixic acid multiple interactions ISO KRAS (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KRAS mRNA CTD PMID:19710929 quercetin multiple interactions ISO KRAS (Homo sapiens) 6480464 [bisphenol A co-treated with Quercetin metabolite] results in increased expression of KRAS mRNA more ... CTD PMID:19424582 and PMID:36982678 quercetin increases expression ISO KRAS (Homo sapiens) 6480464 Quercetin metabolite results in increased expression of KRAS mRNA and Quercetin results in increased expression of KRAS mRNA CTD PMID:36982678 quercetin decreases expression ISO KRAS (Homo sapiens) 6480464 Quercetin results in decreased expression of KRAS mRNA and Quercetin results in decreased expression of KRAS protein CTD PMID:10652438 and PMID:9381980 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of KRAS mRNA CTD PMID:18299717 resveratrol decreases expression ISO KRAS (Homo sapiens) 6480464 resveratrol results in decreased expression of KRAS mRNA and resveratrol results in decreased expression of KRAS protein CTD PMID:12002526 more ... resveratrol multiple interactions ISO KRAS (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of KRAS mRNA CTD PMID:23557933 resveratrol decreases expression ISO Kras (Mus musculus) 6480464 resveratrol results in decreased expression of KRAS protein mutant form CTD PMID:25280562 riddelliine increases mutagenesis ISO Kras (Mus musculus) 6480464 riddelliine results in increased mutagenesis of KRAS gene CTD PMID:13678655 and PMID:20737008 SB 431542 multiple interactions ISO KRAS (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 secobarbital multiple interactions ISO KRAS (Homo sapiens) 6480464 Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 selumetinib multiple interactions ISO KRAS (Homo sapiens) 6480464 AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP3 protein]] more ... CTD PMID:27222248 sevoflurane decreases expression ISO KRAS (Homo sapiens) 6480464 Sevoflurane results in decreased expression of KRAS mRNA CTD PMID:35953652 simvastatin decreases prenylation ISO KRAS (Homo sapiens) 6480464 Simvastatin results in decreased prenylation of KRAS protein CTD PMID:8063617 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of KRAS mRNA CTD PMID:11241755 sodium arsenite multiple interactions ISO Kras (Mus musculus) 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS mRNA and [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS protein CTD PMID:16368122 sodium arsenite affects expression ISO KRAS (Homo sapiens) 6480464 sodium arsenite affects the expression of KRAS protein CTD PMID:17384772 sodium arsenite affects expression ISO Kras (Mus musculus) 6480464 sodium arsenite affects the expression of KRAS mRNA CTD PMID:16507464 sodium arsenite increases expression ISO KRAS (Homo sapiens) 6480464 sodium arsenite results in increased expression of KRAS protein CTD PMID:24431212 and PMID:25804888 sodium arsenite increases expression ISO Kras (Mus musculus) 6480464 sodium arsenite results in increased expression of KRAS mRNA and sodium arsenite results in increased expression of KRAS protein CTD PMID:16014739 and PMID:16507464 Soman increases expression EXP 6480464 Soman results in increased expression of KRAS mRNA CTD PMID:19281266 sotorasib increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in increased susceptibility to sotorasib CTD PMID:31666701 sotorasib affects binding ISO KRAS (Homo sapiens) 6480464 sotorasib binds to KRAS protein mutant form CTD PMID:31666701 sotorasib multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK1 protein] and KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK3 protein] CTD PMID:31666701 styrene increases response to substance ISO Kras (Mus musculus) 6480464 KRAS gene polymorphism results in increased susceptibility to Styrene CTD PMID:12807761 sulfur dioxide increases expression EXP 6480464 Sulfur Dioxide results in increased expression of KRAS mRNA and Sulfur Dioxide results in increased expression of KRAS protein CTD PMID:19434695 sulindac affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein affects the susceptibility to Sulindac CTD PMID:11751493 tacrolimus hydrate increases expression ISO Kras (Mus musculus) 6480464 Tacrolimus results in increased expression of KRAS mRNA CTD PMID:25270620 Tanshinone I decreases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS mRNA results in decreased susceptibility to tanshinone CTD PMID:30506648 Tanshinone I decreases expression ISO KRAS (Homo sapiens) 6480464 tanshinone results in decreased expression of KRAS mRNA and tanshinone results in decreased expression of KRAS protein CTD PMID:30506648 Temsirolimus decreases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form results in decreased susceptibility to temsirolimus CTD PMID:24493623 Temsirolimus multiple interactions ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form inhibits the reaction [temsirolimus inhibits the reaction [CIP2A protein binds to MTOR protein]] more ... CTD PMID:24493623 testosterone enanthate affects expression ISO KRAS (Homo sapiens) 6480464 testosterone enanthate affects the expression of KRAS mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO Kras (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of KRAS mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KRAS mRNA CTD PMID:33387578 tetrachloromethane increases expression ISO Kras (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of KRAS mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KRAS mRNA CTD PMID:31150632 and PMID:8847708 Tetranitromethane increases mutagenesis ISO Kras (Mus musculus) 6480464 Tetranitromethane results in increased mutagenesis of KRAS gene CTD PMID:14713543 thiamylal multiple interactions ISO KRAS (Homo sapiens) 6480464 Thiamylal inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 thimerosal decreases expression ISO KRAS (Homo sapiens) 6480464 Thimerosal results in decreased expression of KRAS mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KRAS mRNA CTD PMID:34492290 tiazofurine multiple interactions ISO KRAS (Homo sapiens) 6480464 Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 tiazofurine decreases expression ISO KRAS (Homo sapiens) 6480464 tiazofurin results in decreased expression of KRAS CTD PMID:9381980 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of KRAS mRNA CTD PMID:16403772 titanium dioxide decreases expression ISO Kras (Mus musculus) 6480464 titanium dioxide results in decreased expression of KRAS mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO Kras (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KRAS mRNA CTD PMID:29950665 titanium dioxide affects expression ISO Kras (Mus musculus) 6480464 titanium dioxide affects the expression of KRAS mRNA CTD PMID:17656681 toluene affects expression EXP 6480464 Toluene affects the expression of KRAS mRNA CTD PMID:21827849 trimetrexate increases response to substance ISO KRAS (Homo sapiens) 6480464 KRAS gene mutant form results in increased susceptibility to Trimetrexate CTD PMID:24688052 Triptolide increases expression EXP 6480464 triptolide results in increased expression of KRAS mRNA CTD PMID:23639586 triptonide increases expression ISO Kras (Mus musculus) 6480464 triptonide results in increased expression of KRAS mRNA CTD PMID:33045310 urethane affects response to substance ISO Kras (Mus musculus) 6480464 KRAS gene affects the susceptibility to Urethane CTD PMID:11807781 urethane decreases expression ISO KRAS (Homo sapiens) 6480464 Urethane results in decreased expression of KRAS mRNA CTD PMID:28818685 urethane increases mutagenesis ISO Kras (Mus musculus) 6480464 Urethane results in increased mutagenesis of KRAS gene CTD PMID:10779650 urethane increases mutagenesis EXP 6480464 Urethane results in increased mutagenesis of KRAS gene CTD PMID:18271921 urethane decreases expression ISO Kras (Mus musculus) 6480464 Urethane results in decreased expression of KRAS mRNA CTD PMID:16289808 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased mutagenesis of KRAS gene] CTD PMID:12839936 valproic acid increases expression ISO KRAS (Homo sapiens) 6480464 Valproic Acid results in increased expression of KRAS mRNA CTD PMID:28001369 vemurafenib affects response to substance ISO KRAS (Homo sapiens) 6480464 KRAS protein mutant form affects the susceptibility to vemurafenib CTD PMID:27222248 vemurafenib multiple interactions ISO KRAS (Homo sapiens) 6480464 [KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP3 protein] more ... CTD PMID:27222248 vinyl carbamate multiple interactions ISO Kras (Mus musculus) 6480464 diallyl sulfone inhibits the reaction [vinyl carbamate results in increased mutagenesis of KRAS gene] CTD PMID:20205516 vinyl carbamate increases mutagenesis ISO Kras (Mus musculus) 6480464 vinyl carbamate results in increased mutagenesis of KRAS gene CTD PMID:20205516 zearalenone decreases expression ISO Kras (Mus musculus) 6480464 Zearalenone results in decreased expression of KRAS mRNA CTD PMID:30717214 zearalenone increases expression ISO Kras (Mus musculus) 6480464 Zearalenone results in increased expression of KRAS mRNA CTD PMID:29758222 zidovudine increases mutagenesis ISO Kras (Mus musculus) 6480464 Zidovudine results in increased mutagenesis of KRAS gene CTD PMID:18800350 zinc protoporphyrin multiple interactions ISO KRAS (Homo sapiens) 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA CTD PMID:22839698 zoledronic acid increases expression ISO KRAS (Homo sapiens) 6480464 zoledronic acid results in increased expression of KRAS protein CTD PMID:28871336